Archive for the ‘Biotech’ Category

Stem Cell Researchers Celebrate Obama Victory, With Caveats

As we mentioned yesterday, the Obama administration is getting a running start, already gearing up to reverse Bush on topics from oil drilling to abortion. And stem cell research, which has been straining under the bonds of various federal funding bans since 1994.

Earlier this year, Obama stated in his Science Debate 2008 response that he “strongly support[s] expanding research on stem cells,” and that:

“As president, I will lift the current administration’s ban on federal funding of research on embryonic stem cell lines created after Aug. 9, 2001 through executive order, and I will ensure that all research on stem cells is conducted ethically and with rigorous oversight.”

Skip forward to today, where democracy has spoken! Hooray for research! Scientists like George Daley, the former president of the International Society for Stem Cell Research, along with many of his colleagues, are understandably thrilled.

Granted, not everyone in the field is busting out the Kristal.

(more…)

November 11th, 2008 Tags: , , ,
by Melissa Lafsky in Biotech, Stem Cells | 0 comments | RSS feed | Trackback >

Let’s Get It Started! Obama Plans Reverse of Bush Science Policies

None too soon, the experts have begun weighing in on what President-Elect Obama should do regarding climate and energy policy. Even better, Obama’s transition team has put together a list of around 200 Bush policies to be kicked to the curb ASAP. They include gems like reversing the limit on federal funding for embryonic stem cell research, and ditching a rule that stops U.S. aid-receiving family planning groups from informing women about the availability of abortion.

The biggest slashes, so far anyway, have been saved for Bush’s environmental policies. As the Washington Post reports, Obama has announced his intention to “quickly reverse the Bush administration’s decision last December to deny California the authority to regulate carbon dioxide emissions from automobiles.” There’s also the undoing of the executive order that opens public lands to oil drilling, as well as social/economic moves like closing Guantanamo and tossing a life preserver to GM (though whether that’s a good idea remains to be seen).

Related:
RB: Obama & McCain Answer DISCOVER’s Questions on the Environment
RB: What Must the Next President Do to Save Science? DISCOVER’s Science Policy Project 2008

November 10th, 2008 Tags: , ,
by Melissa Lafsky in Biotech, Climate Change, Energy, Stem Cells | 4 comments | RSS feed | Trackback >

Obama Wins; Science Rejoices

The new president-elect promises to usher in a “new era of scientific innovation” (of course, exactly how much funding that will entail/receive remains to be seen).

Alternative-energy industries, shrug off your wounds—there may yet be hope on the horizon.

Stem cell researchers, re-start your engines.

Another huge winner last night: The Internet.

Also consider it a huge win for academia: The president-elect, his vice president, and both their spouses have all worked in higher education.

The Senate and the House didn’t do so badly either.

And we hate to do this, but here’s the bad news.

November 5th, 2008 Tags:
by Melissa Lafsky in Climate Change, Energy, Stem Cells, The 2008 Election | 2 comments | RSS feed | Trackback >

What Would Einstein Do? Part XIII: Peter Singer

What are the three most important things the next U.S. president needs to do for science? To cut through the jargon and find an answer, we bring you the DISCOVER Science Policy Project, in which we give a group of the country’s most celebrated scientists and thinkers the chance to state their views. All past responses can be found here.

PETER SINGER
Bioethicist

Free up scientific research on stem cells by revoking Bush’s restriction of research to stem cell lines that were created before his speech in August 2001. It was never defensible to give more protection to embryos consisting of a few cells than we give to sentient beings like dogs and chimpanzees. In any case, thanks to advances in science, the potential for creating a new human life now exists in almost every cell in our body.

(more…)

October 1st, 2008 Tags: , ,
by Melissa Lafsky in Biotech, Discover's Science Policy Project, Stem Cells | 0 comments | RSS feed | Trackback >

GOP Moves to Stamp Out Embryonic Research; McCain (Hopefully) Disagrees

As any lawyer knows, the difference between “and” and “or” can mean winning a seven-figure award versus having your a case tossed out of court. Or, in this case, millions of dollars for stem cell research versus none at all.

It all started last week, when the Republican Platform Committee approved an amendment to the party platform regarding embryonic stem cell research. The change boiled down to that one crucial word—from “and” to “or”—in the platform’s call for the ban of (emphasis added): “the creation of or experimentation on human embryos for research purposes.”

Which means, essentially, is that if the party has its way, virtually all human embryo research, from freezing embryos at fertilization clinics to the privately-financed creation of new stem-cell lines, will be shut down.

(more…)

September 3rd, 2008 Tags: ,
by Melissa Lafsky in Biotech, Science Goes to Washington, Stem Cells, The 2008 Election | 0 comments | RSS feed | Trackback >

Weekly Science & Politics News Roundup

• The Olympics are here! We may not miss a chance to knock China’s political regime, but we’re more than happy to make money on the games—and discuss the smog problem ad nauseum.

• Americans aren’t the only casualty of a shrinking federal budget: Facing lack of funds, the National Center for Atmospheric Research shut down a program focused on helping poor countries forecast and deal with droughts, floods, and other climate-related disasters.

• The latest in obesity research technology: virtual reality studies.

• Researchers have created ten different stem cell lines that can be used for research on diseases from Down’s syndrome to Parkinson’s. And any protesters can relax: They’re all adult stem cells.

(more…)

August 8th, 2008 Tags: ,
by Melissa Lafsky in Biotech, Climate Change, Energy, Nutrition & Obesity, Stem Cells | 1 comments | RSS feed | Trackback >

The Latest in AIDS Research: Pills, Gels, and a Big Step Towards a Cure

microscopeThere’s lots of buzz in the world of AIDS research this week, with the XVII International Conference on AIDS getting ready to kick off in Mexico City. Robert Siliciano, an HIV expert at Johns Hopkins, has found that current antiretroviral drugs have stopped HIV from replicating, the first of three steps needed to cure the virus. Some drug combinations have even squashed the viral cells’ ability to copy themselves to less than one time in a billion. So if the virus can’t spread, what’s left to cure? According to Siliciano’s prior research, HIV hides in reservoirs throughout the body, where it can live without replicating. Curing HIV means finding all of those reservoirs, and then finding a way to eliminate them.

Anti-transmission technologies are also seeing some success in the lab. At St. George’s University of London, a team of researchers led by Martin Cranage has been testing a rectal gel on macaques infected with SIV (the monkey version of the AIDS virus). They found that the gel, which contains the HIV drug tenofovir, partially or totally protected most of the uninfected monkeys from transmission.

(more…)

August 5th, 2008 Tags: ,
by Melissa Lafsky in Biotech, Health Care | 3 comments | RSS feed | Trackback >

Weekly Science & Politics News Roundup

• Anthrax drama! As the Feds close in on a suspect for the 2001 attacks, the top Army microbiologist foils their plan by committing suicide.

• Is contraception the same thing as abortion? Apparently, the answer depends on whether you’re looking at it from a scientific or political perspective.

• After a frantic search, officials finally locate the source of the notorious salmonella-laden peppers—though not before over 250 people were sickened and two died. But did the FDA’s poor communication with states during the process reveal an even deeper management problem?

• The New York Times Magazine delves into the psychology and habits of Internet harassers.

• And, just in time, China relaxes some of its limitations on Internet access for journalists covering the Beijing Olympic games.

• And, in a bout of litigiousness put to good use, Connecticut, New Jersey, Oregon, Pennsylvania and New York City plan to sue the EPA to force the agency to start reducing pollution from ships, aircraft, and off-road vehicles.

August 1st, 2008 Tags: , ,
by Melissa Lafsky in Biotech, Nutrition & Obesity | 0 comments | RSS feed | Trackback >

Reality Check: Biotech

biotechStem Cells
The last three decades have been quite a ride in the world of stem cells. Since they were first isolated in mice in 1981, they’ve rocked the global scientific community with their potential healing abilities—and also sparked massive political and religious debate.

Scientists have been getting results with microRNAs, which have been used to successfully differentiate stem cells, and have even managed to re-start dead animal hearts using cell transplantation. Meanwhile, for women, the stem cells in your menstrual blood may come in handy for your health down the road—though exactly how handy remains to be seen.

And while the longterm political and religious furor over stem cells continues to rage on, the ongoing development of embryonic stem cell-like cells raise scientists’ hopes for miracle cures that would make even the Pope happy.

Bioengineered Meat
Meat is in trouble. Between inhumane farming practices, an increase in livestock-borne diseases, and the problems inherent in generating enough beef, pork, and chicken to feed an ever-growing population, a carnivorous future isn’t looking rosy. So leave it to scientists to begin developing lab-grown meat, created from cells of living animals. The “lab meat movement” has made “glacial progress” in the past few years, to the point where PETA has offered a $1 million prize to the first scientist/s who can “produce commercially viable quantities” of it by 2012. After that, all that’s left is finding a way to rid consumers of the “ick factor.”

(more…)

June 2nd, 2008 by Melissa Lafsky in Biotech, Reality Checks, Stem Cells | 1 comments | RSS feed | Trackback >